Valeo Pharma

Providing healthcare professionals and patients with innovative therapeutic solutions to improve quality of life.

General Information
Company Name
Valeo Pharma
Founded Year
2003
Location (Offices)
Canada +1
Founders / Decision Makers
Number of Employees
88
Industries
Biotechnology, Health Care, Pharmaceutical
Funding Stage
Post Ipo Debt
Social Media

Valeo Pharma - Company Profile

Valeo Pharma is a Canadian pharmaceutical company established in 2003, specializing in the commercialization of innovative prescription products within Respiratory/Allergy, Ophthalmology, and Hospital Specialty Products. With headquarters in Kirkland, Quebec, Valeo Pharma boasts comprehensive capabilities and infrastructure for product registration and management throughout the commercialization process. The company's commitment to improving healthcare is encapsulated in its slogan: "Providing healthcare professionals and patients with innovative therapeutic solutions to improve quality of life." Their fast growth and dedication to enhancing the quality of life through innovative therapeutic solutions make Valeo Pharma an intriguing prospect for potential investors. As an up-and-coming player in the Canadian pharmaceutical landscape, the company presents an attractive investment opportunity. With a sharp focus on addressing unmet medical needs, Valeo Pharma's strategic positioning within the healthcare industry positions it well for future success. For more insights, please visit www.valeopharma.com.

Taxonomy: Pharmaceuticals, Innovative Therapeutic Solutions, Healthcare Professionals, Patients, Quality of Life, Canadian Company, Prescription Products, Respiratory/Allergy, Ophthalmology, Hospital Specialty Products, Commercialization, Product Portfolio Management, Healthcare Innovation, Medical Infrastructure, Canadian Pharmaceutical Industry

Funding Rounds & Investors of Valeo Pharma (10)

View All
Funding Stage Amount No. Investors Investors Date
Post-IPO Debt $5.00M 1 Accord Financial, Inc. (U.S.) 27 Sep 2023
Post-IPO Debt $580.00K - 31 Aug 2023
Post-IPO Equity $3.92M - 31 Aug 2023
Post-IPO Debt $40.00M 1 Sagard Healthcare Royalty Partners 02 Aug 2022
Post-IPO Debt $25.00M 1 09 Dec 2021

View All 10 Funding Rounds

Latest News of Valeo Pharma

View All

No recent news or press coverage available for Valeo Pharma.

Similar Companies to Valeo Pharma

View All
Lei @ Sinotherapeutics Inc - Similar company to Valeo Pharma
Lei @ Sinotherapeutics Inc Focus on the R&D, registration, manufacture and commercialization of complex generic products and innovative formulation
Glacier Pharma - Similar company to Valeo Pharma
Glacier Pharma Glory of Gracious Gesture
Somerset Pharma LLC - Similar company to Valeo Pharma
Somerset Pharma LLC Excellence in Pharmaceuticals
Oakrum Pharma, LLC - Similar company to Valeo Pharma
Oakrum Pharma, LLC Because you matter